Romiplostim Administration to a Preterm Neonate with Severe Prolonged Acquired Thrombocytopenia

Platelet transfusions can be lifesaving for neonates with thrombocytopenic hemorrhage. However, multiple themselves convey risks and hazards. We cared a preterm neonate severe/prolonged acquired thrombocytopenia who received 61 platelet transfusions. Her counts stabilized, further were not needed, following three escalating doses of romiplostim.